Literature DB >> 3543579

[Indications for preventive sclerosing treatment of esophageal varices].

K J Paquet.   

Abstract

There is no doubt that patients with liver cirrhosis, large esophageal varices and extremely elevated intraesophageal variceal pressure have a high risk of variceal bleeding. Telangiectasias on the top of large varices, extremely elevated wedged hepatic venous pressure and a severe reduction of clotting factors are probable risk factors for a variceal hemorrhage, too. Several of these risk factors were analysed in a prospective controlled randomized trial. Endoscopic sclerosis was not only able to reduce the frequency of variceal bleeding but also to prolong life significantly. Thus the value of such risk factors for variceal hemorrhage in patients with liver cirrhosis is well established.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543579     DOI: 10.1007/BF01274323

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  14 in total

1.  [Pathogenesis of bleeding esophageal varices].

Authors:  B Schneider; K Lackner
Journal:  Dtsch Med Wochenschr       Date:  1986-04-18       Impact factor: 0.628

2.  A controlled study of the prophylactic portacaval shunt. A final report.

Authors:  R H Resnick; T C Chalmers; A M Ishihara; A J Garceau; A D Callow; E M Schimmel; E T O'Hara
Journal:  Ann Intern Med       Date:  1969-04       Impact factor: 25.391

3.  A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation.

Authors:  F C Jackson; E B Perrin; A G Smith; A E Dagradi; H M Nadal
Journal:  Am J Surg       Date:  1968-01       Impact factor: 2.565

4.  Endoscopic sclerotherapy of oesophageal varices. A clinical study.

Authors:  C Söderlund
Journal:  Acta Chir Scand Suppl       Date:  1985

5.  Is there an indication for prophylactic endoscopic paravariceal injection sclerotherapy in patients with liver cirrhosis and portal hypertension?

Authors:  K J Paquet; P Koussouris
Journal:  Endoscopy       Date:  1986-05       Impact factor: 10.093

6.  Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial.

Authors:  J Terblanche; P C Bornman; D Kahn; M A Jonker; J A Campbell; J Wright; R Kirsch
Journal:  Lancet       Date:  1983-12-10       Impact factor: 79.321

7.  Intravascular oesophageal variceal pressure (IOVP) assessed by endoscopic fine needle puncture under basal conditions, Valsalva's manoeuvre and after glyceryltrinitrate application.

Authors:  M Staritz; T Poralla; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1985-05       Impact factor: 23.059

8.  Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study.

Authors:  L Witzel; E Wolbergs; H Merki
Journal:  Lancet       Date:  1985-04-06       Impact factor: 79.321

9.  Improved survival following injection sclerotherapy for esophageal varices: final analysis of a controlled trial.

Authors:  D Westaby; B R Macdougall; R Williams
Journal:  Hepatology       Date:  1985 Sep-Oct       Impact factor: 17.425

10.  Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial.

Authors:  K J Paquet
Journal:  Endoscopy       Date:  1982-01       Impact factor: 10.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.